Quick Takeaways
- Phillip Schwartz has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $601,336.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Phillip Schwartz
- Location
- Jerusalem, Israel
- Summary
- The estimated net worth of Phillip Schwartz is at least $601,336 dollars as of 24 Jan 2022. Phillip Schwartz is the President of R&D, Director of Entera Bio Ltd. and owns shares of Entera Bio Ltd. (ENTX) stock worth about $601.3K.
- Signature
- /s/ Dana Yaacov-Garbeli, Attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Phillip Schwartz and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Entera Bio Ltd. ($601,336).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Phillip Schwartz
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ENTX | Entera Bio Ltd. | President of R&D, Director | $601,336 | 20 Jan 2022 |
Insider Transactions Reported by Phillip Schwartz:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.